View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. EMBO CAPS® by Suheung
10 August 2018

Visit Suheung Capsule’s Booth at CPhI Worldwide

Suheung Capsule has announced it will be attending CPhI Worldwide.

Taking place from 9 October to 11 October in IFEMA in Feria de Madrid, Spain, this event connects pharmaceutical products, people and solutions to increase business relationships and encourage innovation in the industry.

Suheung aims to produce high-quality products and is a global name in quality and innovation in the capsule industry. Produced at its ultramodern current good manufacturing practice (cGMP) facilities, each capsule is crafted using state-of-the-art manufacturing processes and systems.

Suheung specialises in the production of empty hard capsules for use in pharmaceutical and nutraceutical applications. The company enjoys strong global competitiveness in quality and the uniqueness of its patented empty hard capsules: EMBO CAPS®.

Suheung Capsule also offers contract manufacturing services to the pharmaceutical and nutraceutical industries with a wide variety of dosage types and packaging options. Suheung Capsule will continue its challenge to provide real value to its customers through quality and innovation.

The company will be present at booth 8G80, showcasing its excipients, finished dosage formulations, capsules and encapsulation technologies.

The EMBO CAPS® products include:

This MAPP establishes the policy in the Office of Pharmaceutical Quality (OPQ) for a postapproval change in the supplier of a hard gelatin capsule shell.
The purpose of this MAPP is to establish the policy in the Office of Pharmaceutical Quality (OPQ) for a postapproval change in the supplier of...
The purpose of this white paper is to compare the equivalence of empty pharmaceutical hard capsules with various traditional raw materials such as gelatin and...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology